Behavior of viral hepatitis C in patients from hemodialysis program from Hospital São Lucas da PUCRS <b>[Abstract in English]</b>
Keywords:
Hepatite viral CAbstract
Aims: To evaluate the prevalence of antibodies against hepatitis C virus in patients undergoing hemodialysis and to investigate the present condition of 71 patients who participated in a study conducted at the same hemodialysis unit from 2000 to 2002.
Methods: Patients seropositive for hepatitis C virus (anti-HCV reactive) were identified among those undergoing hemodialysis at Hospital São Lucas da PUCRS in May 2006. Seventy-one patients who underwent hemodialysis from a previous study (2000-2002) of prevalence of HCV were also studied. These subjects were followed through medical records. The results were described and compared with the literature.
Results: I May 2006, among the 70 patients undergoing hemodialysis at DU-SLH, 7 (10%) were anti-HCV reactive. Regarding the 71 patients from the 2000-2002 study, 24 (33.8%) still attend São Lucas Hospital, 12 (16.9%) undergoing hemodialysis and 12 (16.9%) after renal transplantation. Twenty two patients (31%) have dyed, the majority of them due to cardiovascular causes. Twenty five (35.2%) patients are no more in contact with the Institution.
Conclusions: Anti-HCV prevalence detected among patients undergoing hemodialysis in May 2006 was significantly different from that observed in the 2000-2002 study. Apparently, hepatitis C infection had no influence on the mortality or prognosis of anti-HCV positive patients from the 2000-2002 study, once the major registered cause of death was cardiovascular problems.
KEY WORDS: HEPATITIS C; PREVALENCE; HEPATITIS C ANTIBODIES; HEMODIALYSIS UNITS, HOSPITAL; HEMODIALYSIS.
Downloads
Downloads
How to Cite
Issue
Section
License
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.